Imagion Biosystems Limited (ASX:IBX)
Australia · Delayed Price · Currency is AUD 0.0080
0.00 (0.00%)
Sep 7, 2026, 9:59 AM AEST
Imagion Biosystems Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.03 | 1.85 | 2.67 | 0.23 | 4.45 | 13.39 |
Cash & Short-Term Investments | 0.03 | 1.85 | 2.67 | 0.23 | 4.45 | 13.39 |
Cash Growth | -96.33% | -30.81% | 1076.00% | -94.89% | -66.81% | 1.46% |
Accounts Receivable | 0.57 | 0.02 | 0 | 0.07 | 0.09 | 0.03 |
Other Receivables | - | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
Receivables | 0.57 | 0.03 | 0.03 | 0.1 | 0.11 | 0.06 |
Prepaid Expenses | - | 0.15 | 0.08 | 0.14 | 0.32 | 0.17 |
Other Current Assets | 0.07 | 0.01 | - | 0.13 | 0.11 | 0.14 |
Total Current Assets | 0.67 | 2.04 | 2.79 | 0.6 | 4.99 | 13.77 |
Property, Plant & Equipment | 0.01 | 0.01 | 0.02 | 3.98 | 4.99 | 0.35 |
Total Assets | 0.67 | 2.04 | 2.8 | 4.59 | 9.98 | 14.12 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 1.9 | 1.2 | 2.07 | 1.59 | 0.33 | 0.43 |
Accrued Expenses | - | - | - | 0.26 | 0.18 | 0.14 |
Current Portion of Long-Term Debt | 2.19 | 2.66 | 2.79 | 1.7 | - | - |
Current Portion of Leases | - | 0.04 | 0.05 | 1.1 | 1.04 | 0.02 |
Other Current Liabilities | - | 0.32 | 0.17 | 0.48 | 0.19 | 0.19 |
Total Current Liabilities | 4.09 | 4.21 | 5.09 | 5.13 | 1.73 | 0.78 |
Long-Term Debt | - | - | - | 0.75 | - | - |
Long-Term Leases | - | - | - | 2.49 | 3.56 | 0.03 |
Pension & Post-Retirement Benefits | - | - | - | 0 | 0 | 0 |
Total Liabilities | 4.09 | 4.21 | 5.09 | 8.37 | 5.3 | 0.81 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 66.58 | 65.96 | 62.54 | 59.61 | 56.83 | 56.83 |
Retained Earnings | -72.9 | -71.32 | -67.01 | -68.32 | -55.84 | -46.03 |
Comprehensive Income & Other | 2.9 | 3.2 | 2.19 | 4.92 | 3.69 | 2.51 |
Shareholders' Equity | -3.42 | -2.16 | -2.28 | -3.79 | 4.68 | 13.31 |
Total Liabilities & Equity | 0.67 | 2.04 | 2.8 | 4.59 | 9.98 | 14.12 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2.19 | 2.69 | 2.85 | 6.04 | 4.6 | 0.05 |
Net Cash (Debt) | -2.16 | -0.84 | -0.18 | -5.81 | -0.16 | 13.35 |
Net Cash Growth | - | - | - | - | - | 6.44% |
Net Cash Per Share | -0.01 | -0.00 | -0.00 | -0.19 | -0.01 | 0.51 |
Filing Date Shares Outstanding | 539.94 | 490.59 | 201.34 | 32.65 | 28.03 | 28.03 |
Total Common Shares Outstanding | 539.94 | 487.54 | 201.34 | 32.65 | 28.03 | 28.03 |
Working Capital | -3.43 | -2.17 | -2.3 | -4.53 | 3.26 | 12.99 |
Book Value Per Share | -0.01 | -0.00 | -0.01 | -0.12 | 0.17 | 0.47 |
Tangible Book Value | -3.42 | -2.16 | -2.28 | -3.79 | 4.68 | 13.31 |
Tangible Book Value Per Share | -0.01 | -0.00 | -0.01 | -0.12 | 0.17 | 0.47 |
Machinery | - | 0.1 | 0.11 | 1.28 | 1.1 | 0.86 |
Leasehold Improvements | - | - | - | 0.55 | 0.56 | 0.24 |